[1
]Istituto Nazionale Tumori, Fondazione “G. Pascale”, Naples, Italy
[2
]Center for Cancer Research, National Cancer Institute, National Institutes of Health,
Bethesda, MA, USA
[3
]Plastic and Reconstructive Surgery, Regional Melanoma Refferral Center – S.M. Annunziata
Hospital, Florence, Italy
[4
]Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano
Tumori, Siena, Italy
[5
]WHO Melanoma Program, Milan, Italy
[6
]Nodality Inc, South San Francisco, USA
[7
]Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan,
Italy
[8
]Cancer Institute Gustave Roussy, Villejuif, Paris-Sud, France
[9
]John Wayne Cancer Institute, Santa Monica, CA, USA
[10
]Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston,
MA, USA
[11
]Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute,
Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA
[12
]Department of Molecular Microbiology and Immunology, Oregon Health and Science University,
Portland, OR, USA
[13
]University of Chicago, Chicago, IL, USA
[14
]INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris F-75006, France
[15
]Université Paris Descartes, Paris, France
[16
]Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris,
France
[17
]Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
[18
]1st Department of Medicine, Medical School, University of Athens, Athens, Greece
[19
]Center for Melanoma Research and Treatment, California Pacific Medical Center Research
Institute, San Francisco, CA, USA
[20
]Rush University, Chicago, IL, USA
[21
]Royal Marsden NHS Foundation Trust, London, UK
[22
]Dermatology/Medicine, UCLA Geffen School of Medicine and Jonsson Comprehensive Cancer
Center, Los Angeles, CA, USA
[23
]Humanitas Clinical and Research Institute, Rozzano, Italy
[24
]Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of
Washington, Seattle, WA, USA
[25
]Leiden University Medical Center and ISA Pharmaceuticals, Leiden, The Netherlands
[26
]Peter MacCallum Cancer Centre, East Melbourne, Australia
[27
]Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council,
Sassari, Italy
[28
]Vanderbilt University Medical Center, Nashville, TN, USA
[29
]Tumor Immunology Program, Jonsson Comprehensive Cancer Center (JCCC), David Geffen
School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA,
USA
[30
]Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle,
Germany
[31
]Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA
[32
]Global Early Clinical Development, Clinical Immunotherapeutics, Immunotherapeutics,
GlaxoSmithKline Vaccines, Rixensart, Belgium
[33
]University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
[34
]Cancer and Inflammation Program, Center for Cancer Research, NCI, NIH, Frederick,
MD, USA
[35
]Institute of Applied Molecular Medicine (IMMA), CEU-San Pablo University and HM-Hospitals
School of Medicine, Boadilla del Monte, 28668, Madrid, Spain
[36
]Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine,
Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda, MD, USA
[37
]Sidra Medical and Research Centre, Doha, Qatar
[38
]Cancer Diagnosis Program. NCI, NIH, Bethesda, MD, USA
License:
This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (
http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.